Ken Griffin acquired 150 Thousand Theravance Biopharma shares worth $1.35 Million. That's 0.00% of their equity portfolio (2581st largest holding). The first Theravance Biopharma trade was made in Q2 2014. Since then Ken Griffin bought shares 25 more times and sold shares on 30 occasions. The investor's estimated purchase price is $1.45 Million, resulting in a loss of 6.5%.